Evidence map›Paper›PMID 38808037›Full record

ArticleVirus evolution2024

Long-term evolution of human seasonal influenza virus A(H3N2) is associated with an increase in polymerase complex activity.

René M Vigeveno, Alvin X Han, Robert P de Vries, Edyth Parker, Karen de Haan, Sarah van Leeuwen, Katina D Hulme, Adam S Lauring, Aartjan J W Te Velthuis, Geert-Jan Boons and 4 more

Abstract read
In one paragraph

Article in Virus evolution, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

René M VigevenoDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam, The Netherlands.
Alvin X HanDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam, The Netherlands.
Robert P de VriesDepartment of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.ORCID https://orcid.org/0000-0002-1586-4464
Edyth ParkerDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam, The Netherlands.
Karen de HaanDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam, The Netherlands.
Sarah van LeeuwenDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam, The Netherlands.
Katina D HulmeDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam, The Netherlands.
Adam S LauringDepartment of Microbiology and Immunology and Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, 1150 W. Medical Center Dr., Ann Arbor, MI 48109, USA.ORCID https://orcid.org/0000-0003-2906-8335
Aartjan J W Te VelthuisLewis Thomas Laboratory, Department of Molecular Biology, Princeton University, Washington Road, Princeton, NJ 08544, USA.ORCID https://orcid.org/0000-0002-5129-3953
Geert-Jan BoonsDepartment of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Ron A M FouchierDepartment of Viroscience, Erasmus MC, Dr. Molewaterplein 50, Rotterdam 3015 GE, The Netherlands.
Colin A RussellDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-2113-162X
Menno D de JongDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam, The Netherlands.
Dirk EgginkDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-4248-6008

Funding

Functional and genetic constraints on influenza virus replication and fidelityR01AI170520 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAURING, ADAM · 2022 to 2025
$2.4M
Structure and dynamics of RNA elements regulating viral aberrant RNA synthesisDP2AI175474 · NIAID · PRINCETON UNIVERSITY · PI TE VELTHUIS, AREND JAN · 2022 to 2025
$2.4M
NIAID NIH HHS DP2 AI175474NIAID NIH HHS R01 AI170520
6 · The paper itself

Abstract

Since the influenza pandemic in 1968, influenza A(H3N2) viruses have become endemic. In this state, H3N2 viruses continuously evolve to overcome immune pressure as a result of prior infection or vaccination, as is evident from the accumulation of mutations in the surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). However, phylogenetic studies have also demonstrated ongoing evolution in the influenza A(H3N2) virus RNA polymerase complex genes. The RNA polymerase complex of seasonal influenza A(H3N2) viruses produces mRNA for viral protein synthesis and replicates the negative sense viral RNA genome (vRNA) through a positive sense complementary RNA intermediate (cRNA). Presently, the consequences and selection pressures driving the evolution of the polymerase complex remain largely unknown. Here, we characterize the RNA polymerase complex of seasonal influenza A(H3N2) viruses representative of nearly 50 years of influenza A(H3N2) virus evolution. The H3N2 polymerase complex is a reassortment of human and avian influenza virus genes. We show that since 1968, influenza A(H3N2) viruses have increased the transcriptional activity of the polymerase complex while retaining a close balance between mRNA, vRNA, and cRNA levels. Interestingly, the increased polymerase complex activity did not result in increased replicative ability on differentiated human airway epithelial (HAE) cells. We hypothesize that the evolutionary increase in polymerase complex activity of influenza A(H3N2) viruses may compensate for the reduced HA receptor binding and avidity that is the result of the antigenic evolution of influenza A(H3N2) viruses.

Indexed as

antigenic driftevolutionH3N2Influenza viruspolymerase complex activityreceptor specificity

Identifiers

PMID38808037
PMCPMC11131032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.